Literature DB >> 6945043

Stability of anthracycline antitumor agents in four infusion fluids.

G K Poochikian, J C Cradock, K P Flora.   

Abstract

The stabilities of doxorubicin hydrochloride, daunorubicin hydrochloride, zorubicin, and aclacinomycin A hydrochloride were studied in various infusion fluids at ambient temperature. Reversed-phase high-pressure liquid chromatographic procedures developed and used in these studies employed internal standards and readily separated each drug from its degradation products. Dilute solutions of the anthracyclines were prepared by appropriate dilutions of the reconstituted solutions of the formulated products with 5% Dextrose Injection, USP (D5W); 0.9% Sodium Chloride Injection, USP (NS); Lactated Ringer's Injection, USP (LR); and Normosol-R pH 7.4. The stability of the anthracyclines was dependent on the pH of the admixture solution which, in turn, was dependent on infusion fluid composition. Daunorubicin and aclacinomycin A exhibited acceptable stability (equal to 90% of the original concentration) in D5W, NS, and LR for more than 48 hours. Doxorubicin manifested similar stability in the first two fluids. Zorubicin showed similar stability only in Normosol-R pH 7.4 fluid for 22 hours.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6945043

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  9 in total

1.  Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.

Authors:  T Dine; J C Cazin; B Gressier; M Luyckx; C Brunet; M Cazin; F Goudaliez; M L Mallevais; I Toraub
Journal:  Pharm Weekbl Sci       Date:  1992-12-11

Review 2.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  A rapid bioassay to determine stabilities of anticancer agents under conditions of the clonogenic assay.

Authors:  S U Hildebrand-Zanki; D H Kern
Journal:  In Vitro Cell Dev Biol       Date:  1986-05

4.  Aspects of the chemical stability of doxorubicin and seven other anthracyclines in acidic solution.

Authors:  J H Beijnen; G Wiese; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1985-06-21

Review 5.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

6.  Troglitazone reduces glyoxalase I protein expression in glioma and potentiates the effects of chemotherapeutic agents.

Authors:  Jeffrey Helgager; Jie Li; Irina A Lubensky; Russell Lonser; Zhengping Zhuang
Journal:  J Oncol       Date:  2010-05-04       Impact factor: 4.375

Review 7.  A review of the stability and compatibility of antineoplastic drugs for multiple-drug infusions.

Authors:  D A Williams; J Lokich
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  The influence of pH and temperature on the stability of N-[(piperidine)methylene]daunorubicin Hydrochloride and a comparison of the stability of daunorubicin and its four new amidine derivatives in aqueous solutions.

Authors:  Mikołaj Piekarski; Agnieszka Dołhań; Judyta Cielecka-Piontek; Przemysław Zalewski; Witold Kycler; Aleksandra Kaczmarek; Artur Firlej; Irena Oszczapowicz; Anna Jelińska
Journal:  ScientificWorldJournal       Date:  2014-02-06

9.  Substandard Cisplatin Found While Screening the Quality of Anticancer Drugs From Addis Ababa, Ethiopia.

Authors:  Madeline S Eberle; Ayenew Ashenef; Heran Gerba; Patrick J Loehrer; Marya Lieberman
Journal:  JCO Glob Oncol       Date:  2020-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.